Abstract
The advent of molecular genetic technologies paved a path for the diagnosis of many neurological disorders. Joint evaluation by a neurologist and a medical genetics specialist can potentially increase diagnostic effectiveness by ensuring the exclusion of non-genetic conditions with similar phenotypes and by rationally selecting appropriate genetic diagnostic tools. Therefore, a monthly adult neurogenetics clinic was established. A retrospective review of medical records of all patients who attended the clinic from April 2015 to March 2019 was conducted. Eighty-two patients were evaluated (age: 47.1 ± 15.7, male: 37(45%), 42 (51%) had a positive family history). Disease duration was typically long (11.4 ± 0.9 years). Futile use of diagnostic modalities was very common (45 (55%) had repeated MRI, 28 (34%) hospitalized for observation in neurologic departments, 12 (14%) had a normal metabolic workup, 4 (5%) with a non-conclusive muscle biopsy, 1 with a normal cerebral angiography). Following clinical evaluation, molecular genetic testing was offered to 67 (82%) patients. In the other 15 (18%), routine workup for the exclusion of non-genetic conditions was not complete; obtainable information regarding family members was missing or that a neurogenetic disorder seemed improbable. Twenty-seven (33%) patients received a definitive diagnosis, either a genetic (23, 28%) or non-genetic (4, 5%). Excluding 4 cases of pre-symptomatic diagnosis, the diagnostic yield was 30%. The adherence to genetic testing recommendations was 62%. The reasons for non-adherence were lack of public funding for the required test (52%) and patient decision not to proceed (48%). Given the frequent futile use of diagnostic modalities, referral of non-genetic conditions with similar phenotypes among neurogenetic disorders, and the complexity of clinical genomic data analysis, a multi-disciplinary neurogenetics clinic seems justified.
Similar content being viewed by others
References
Alkanderi S, Yates LM, Johnson SA, Sayer JA (2017) Lessons learned from a multidisciplinary renal genetics clinic. QJM 110:453–457. https://doi.org/10.1093/qjmed/hcx030
Battista RN, Blancquaert I, Laberge AM et al (2011) Genetics in health care: an overview of current and emerging models. Public Health Genomics 15:34–45. https://doi.org/10.1159/000328846
Burns TM, Mauermann ML (2011) The evaluation of polyneuropathies. Neurology 76(7 Suppl 2):S6-13. https://doi.org/10.1212/WNL.0b013e31820c3622
Dunnenberger HM, Biszewski M, Bell GC et al (2016) Implementation of a multidisciplinary pharmacogenomics clinic in a community health system. Am J Heal Pharm 73:1956–1966. https://doi.org/10.2146/ajhp160072
Edlefsen KL, Tait JF, Wener MH, Astion M (2007) Utilization and diagnostic yield of neurogenetic testing at a tertiary care facility. Clin Chem 53:1016–1022. https://doi.org/10.1373/clinchem.2006.083360
Fernández IS, Loddenkemper T, Gaínza-Lein M et al (2019) Diagnostic yield of genetic tests in epilepsy: a meta-analysis and cost-effectiveness study. Neurology 92:E418–E428. https://doi.org/10.1212/WNL.0000000000006850
Gahl WA, Markello TC, Toro C et al (2012) The national institutes of health undiagnosed diseases program: insights into rare diseases. Genet Med 14:51–59. https://doi.org/10.1038/gim.0b013e318232a005
Garg N, Park SB, Vucic S et al (2017) Differentiating lower motor neuron syndromes. J Neurol Neurosurg Psychiatry 88:474–483. https://doi.org/10.1136/jnnp-2016-313526
Gorcenco S, Ilinca A, Almasoudi W et al (2020) New generation genetic testing entering the clinic. Park Relat Disord 73:72–84. https://doi.org/10.1016/j.parkreldis.2020.02.015
Hartley T, Lemire G, Kernohan KD et al (2020) New diagnostic approaches for undiagnosed rare genetic diseases. Annu Rev Genomics Hum Genet 21:351–372
Hellmann MA, Kakhlon O, Landau EH et al (2015) Frequent misdiagnosis of adult polyglucosan body disease. J Neurol 262:2346–2351. https://doi.org/10.1007/s00415-015-7859-4
Maggi L, Bello L, Bonanno S et al (2020) Nusinersen safety and effects on motor function in adult spinal muscular atrophy type 2 and 3. J Neurol Neurosurg Psychiatry 91:1166–1174. https://doi.org/10.1136/jnnp-2020-323822
Mallett A, Fowles LF, McGaughran J et al (2016) A multidisciplinary renal genetics clinic improves patient diagnosis. Med J Aust 204:58–59. https://doi.org/10.5694/mja15.01157
Olszewska DA, McVeigh T, Fallon EM et al (2018) The benefits of a Neurogenetics clinic in an adult Academic Teaching Hospital. Ir J Med Sci 187:1073–1076. https://doi.org/10.1007/s11845-018-1784-3
Rodríguez-Quiroga SA, Cordoba M, González-Morón D et al (2015) Neurogenetics in Argentina: diagnostic yield in a personalized research based clinic. Genet Res (Camb) 97:e10. https://doi.org/10.1017/s0016672315000087
Stark Z, Schofield D, Alam K et al (2017) Prospective comparison of the cost-effectiveness of clinical whole-exome sequencing with that of usual care overwhelmingly supports early use and reimbursement. Genet Med 19:867–874. https://doi.org/10.1038/gim.2016.221
Wahbi K, Furling D (2020) Cardiovascular manifestations of myotonic dystrophy. Trends Cardiovasc Med 30:232–238
Weisfeld-Adams JD, Sand IBK, Honce JM, Lublin FD (2015) Differential diagnosis of Mendelian and mitochondrial disorders in patients with suspected multiple sclerosis. Brain 138:517–539
Zentner D, Thompson TN, James PA et al (2015) The cardiac genetics clinic: A model for multidisciplinary genomic medicine. Med J Aust 203:261.e1-261.e6. https://doi.org/10.5694/mja14.01674
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethics approval and consent to participate
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Peleg, A., Sagi-Dain, L. & Golan, D. Diagnostic yield and recognized barriers of an adult neurogenetics clinic. J Community Genet 12, 569–576 (2021). https://doi.org/10.1007/s12687-021-00547-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12687-021-00547-y